Literature DB >> 9650569

Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress.

A Treister1, O Sagi-Assif, M Meer, N I Smorodinsky, R Anavi, I Golan, T Meshel, O Kahana, R Eshel, B Z Katz, E Shevach, I P Witz.   

Abstract

Ly-6E.1 is highly expressed in murine tumor cells with a high malignancy phenotype and may serve as a marker for such a phenotype. In this study, we examined the effects of various growth conditions and stress on the expression levels of Ly-6E.1 by tumor cells. Previous preliminary results have shown that murine DA3 mammary tumor cells expressing high levels of Ly-6E.1 (Ly-6(hi)) are more highly tumorigenic than the same tumor cells expressing low levels of this membrane protein (Ly-6(lo)). In this study, we demonstrate that mice bearing Ly-6(hi) DA3 tumors have a significantly higher burden of spontaneous pulmonary metastasis than mice bearing Ly-6(lo) DA3 tumors. Furthermore, the survival time of the former mice was significantly shorter than that of the latter ones. We further show that certain other members of the Ly-6 gene family such as Ly-6C.1 and Ly-6G.1 are coregulated with Ly-6E.1. This was shown to occur with respect to both DA3 cells as well as A3 tumor cells which are of fibroblast origin. However, these 2 cells differ with respect to regulation of Sca-2 (TSA1, another member of the Ly-6 family) expression on these cells. Levels of Sca-2 on A3 cells appear to be coregulated with Ly-6E.1 (i.e., Ly-6(hi) A3 cells express high levels of Sca-2 and Ly-6(lo) A3 cells express low levels of Sca-2). These 2 Ly-6 proteins were, however, not coregulated on DA3 cells. Both Ly-6(hi) as well as Ly-6(lo) DA3 cells express equal levels of Sca-2. Levels of Thy-1, another glycosylphosphatidylinositol (GPI)-anchored protein expressed by A3 tumor cells, were equally expressed by both Ly-6(hi) and Ly-6(lo) A3 tumor cells. Levels of Ly-6 (but not those of CD44) on A3 tumor cells were upregulated on cells from dense cultures but were not influenced by the position of the cells in the cell cycle. Stress conditions such as serum starvation or heat shock upregulated the expression of Ly-6 by the 2 types of tumor cells but did not induce apoptosis in these cells. The kinetics of the stress-dependent upregulation of Ly-6 expression differed, however, between the epithelial and fibroblastic tumor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650569     DOI: 10.1002/(sici)1097-0215(19980717)77:2<306::aid-ijc22>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.

Authors:  Geeta Upadhyay; Yuzhi Yin; Hongyan Yuan; Xin Li; Rik Derynck; Robert I Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptorγ activation.

Authors:  Hongyan Yuan; Geeta Upadhyay; Yuzhi Yin; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

3.  Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.

Authors:  S Ross; S D Spencer; L A Lasky; H Koeppen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice.

Authors:  S X Cao; J M Dhahbi; P L Mote; S R Spindler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

5.  Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration.

Authors:  Kimberly A Kafadar; Lin Yi; Yusra Ahmad; Leslie So; Fabio Rossi; Grace K Pavlath
Journal:  Dev Biol       Date:  2008-11-06       Impact factor: 3.582

Review 6.  Prostate stem cell antigen: a prospective therapeutic and diagnostic target.

Authors:  Adam B Raff; Andrew Gray; W Martin Kast
Journal:  Cancer Lett       Date:  2008-10-05       Impact factor: 8.679

7.  Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer.

Authors:  Ran-Ju Kim; Soo-Rim Kim; Kyung-Jin Roh; Sang-Bum Park; Jeong-Ran Park; Kyung-Sun Kang; Gu Kong; Binwu Tang; Yu-An Yang; Ethan A Kohn; Lalage M Wakefield; Jeong-Seok Nam
Journal:  Cancer Lett       Date:  2009-07-07       Impact factor: 8.679

8.  Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.

Authors:  Yu-Chiao Hsu; Kurt Mildenstein; Kordell Hunter; Olena Tkachenko; Craig A Mullen
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 9.  Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

Authors:  Harm Westdorp; Annette E Sköld; Berit A Snijer; Sebastian Franik; Sasja F Mulder; Pierre P Major; Ronan Foley; Winald R Gerritsen; I Jolanda M de Vries
Journal:  Front Immunol       Date:  2014-05-06       Impact factor: 7.561

10.  Expression of Ly-6D on the surface of normal and neoplastic mammary epithelial cells of the mouse.

Authors:  Yasukatsu Tsukada; Tetsuo Sasaki; Kazuhide Hanyu; Jumpei Enami
Journal:  Jpn J Cancer Res       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.